Dual-targeted CAR-T cells have been shown to be effective against breast cancer too [95], for example, with CAR-T cells equipped with a split dual-antigen targeting system that required simultaneous activation upon engagement with ErbB2 and MUC1 TAAs. Here, ERBB2 is linked to breast carcinoma.